Arbele, a leading innovator in biopharmaceutical and biotechnology focused on targeting cadherin-17 (CDH17), has announced a strategic collaboration in precision oncology using artificial intelligence (AI) to advance targeted immunotherapeutics of...
The Indian pharmaceutical market (IPM) experienced a 5.3% growth in September this year, fueled by significant therapies demonstrating favorable value growth, reported by Pharmarack. Urology, cardiac, and dermatology treatments experienced close...
Zydus Lifesciences Ltd announced that it has been granted final approval by the FDA to produce paliperidone extended-release tablets in doses of 1.5 mg, 3 mg, 6 mg, and 9 mg. Paliperidone extended-release tablets are prescribed for treating...
Aerogen, a leading global company in acute-care aerosol drug delivery based in Ireland, partnered with the Indian Association of Respiratory Care (IARC) to advance respiratory therapy education and enhance patient care throughout India...
India's pharmaceutical and meditech sectors are projected to continue their growth momentum throughout the current fiscal year despite a global economic slowdown, A senior government official stated. Secretary Arunish Chawla announced on the...
.webp)
Bayer and MOMA Therapeutics, Inc., a biopharmaceutical company in the clinical stage that focuses on discovering and creating precise therapeutics, have declared a collaboration. This partnership involves an option and exclusive license agreement...
Zealand Pharma A/S, a biotech company specializing in peptide-based drugs, revealed that the FDA has issued a Complete Response Letter (CRL) for Part 1 of the NDA for dasiglucagon for treating hypoglycemia in children with CHI. The CRL is...
Aurigene Oncology Limited, a subsidiary of Dr Reddy’s Laboratories Limited, is dedicated to developing innovative treatments for cancer and has released phase 1 findings for DRL-1801 in the SWASTH study - India's initial trial for a new CAR-T cell...
ModeX Therapeutics Inc, a biotechnology company under OPKO Health, Inc., reveals that it has received $35 million more in funding from BARDA, a branch of HHS responsible for Strategic Preparedness and Response in the US. The firm will start...
Boehringer Ingelheim, a biopharmaceutical company involved in human and animal health, revealed that the FDA has given Breakthrough Therapy status to survodutide (BI 456906), a dual glucagon/GLP-1 receptor agonist for treating adults with non...
, CDSCO.jpg)
.jpg)